ShareValue scores for PHGN34.SA: Valuation 65, Quality 31, Growth 50, Health 38.

PHGN34.SA
B3

Koninklijke Philips N.V.

R$135.66(+1.71%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

3% to 18%
Valuation
65
Fair Value
Price vs Value
Quality
31
Weak
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
38
Stressed
Financial Stability
Momentum
41
Neutral
Price Trend

Company Details

About

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026